Objective. ADAMs are a gene family of multifunctional proteins. We undertook this study to determine which ADAM species is up-regulated in osteoarthritic (OA) cartilage and to examine its pathobiologic function.Methods. Expression of the 13 different metalloproteinase-type ADAMs was screened by reverse transcription-polymerase chain reaction (PCR), and expression levels of prototype membrane-anchored ADAM-12 (ADAM-12m) were determined by real-time PCR. ADAM-12m expression in articular cartilage was examined by in situ hybridization, immunohistochemistry, and immunoblotting. Chondrocytes were used for functional analyses of ADAM-12m.Results. ADAM-12m was selectively expressed in 87% of OA cartilage, and the expression level was significantly higher in OA cartilage than in normal cartilage. In situ hybridization showed that OA chondrocytes were responsible for the expression. Osteoarthritis (OA) is characterized by the breakdown of articular cartilage, leading to pain and loss of joint function. Articular cartilage is a narrow layer of specialized extracellular matrix, consisting primarily of collagens and proteoglycans, that is elaborated and maintained by a small number of articular chondrocytes. In normal cartilage, chondrocytes sustain a balance between the synthesis and the degradation of matrix components, resulting in stability of the tissue over time. This equilibrium is disturbed in degenerative joint diseases such as OA (1). Chondrocyte cloning, also known as chondrocyte cluster formation, is a major characteristic phenotype of OA cartilage (2), and it could reflect